Company & Sponsor Intelligence
Douglas Mental Health University Institute
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials5
Recruiting2
Completed3
Countries1
Therapeutic footprint
alzheimersother_psychiatryschizophrenia
Indexed studies
NCT06038643Intergenerational Behavioral Intervention to Enhance Physical Activity in Older Adults at Risk for Alzheimer's Disease
alzheimers · CanadaNA
alzheimers · CanadaNA
NCT07213349Daridorexant for Alzheimer Disease Prevention
alzheimers · CanadaPHASE2
alzheimers · CanadaPHASE2
NCT06893393Virtual Travel Into Nature for Individuals With Lived Experience of Severe Mental Disorders
other_psychiatry · CanadaNA
other_psychiatry · CanadaNA
NCT06978894Predicting Psychotic Relapse Using Speech-Based Early Detection
schizophrenia · CanadaRECRUITING
schizophrenia · CanadaRECRUITING
NCT02702817Randomized Trial of Low-dose Naproxen in Cognitively Intact Persons at Risk of Alzheimer's Dementia
alzheimers · CanadaPHASE2
alzheimers · CanadaPHASE2
Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →